Genomic alterations in breast cancer patients in betel quid and non betel quid chewers

PLoS ONE

Volumn 7, Issue 8, 2012, Pages

  Kaushal, Mishi ^a   Mishra, Ashwani K ^a   Sharma, Jagannath ^b   Zomawia, Eric ^c   Kataki, Amal ^b   Kapur, Sujala ^a   Saxena, Sunita ^a  

^a SAFDARJUNG HOSPITAL   (India)

^b A Unit of Tata Memorial Centre   (India)

^c CIVIL HOSPITAL   (India)

Author keywords

[No Author keywords available]

Indexed keywords

ALDO KETO REDUCTASE; OXIDOREDUCTASE; PROTEIN KINASE; UNCLASSIFIED DRUG;

ARECA; ARTICLE; BETEL QUID CHEWING; BLCAP GENE; BREAST CANCER; BREAST CARCINOGENESIS; CANCER PATIENT; CANCER RISK; CHROMOSOMAL LOCALIZATION; CHROMOSOME 1; EMR3 GENE; ENZYME ACTIVITY; GENE; GENE FUNCTION; GENETIC ASSOCIATION; GENETIC RISK; GENETIC TRANSFORMATION; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MASTICATION; MUC16 GENE; NNAT GENE; RISK ASSESSMENT; RPN2 GENE; SINGLE NUCLEOTIDE POLYMORPHISM; VAV1 GENE; X CHROMOSOME;

ADULT; ARECA; BREAST NEOPLASMS; CARCINOMA, SQUAMOUS CELL; FEMALE; GENE EXPRESSION PROFILING; GENOME, HUMAN; HUMANS; MASTICATION; MIDDLE AGED; POLYMORPHISM, SINGLE NUCLEOTIDE;

EID: 84865279791     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0043789     Document Type: Article

References (70)

1. Tchatchou S, Burwinkel B, (2008) Chromosome copy number variation and breast cancer risk. Cytogenet Genome Res 123: 183-187.
2. IARC website, Available at http://globocan.iarc.fr accessed on 31 January 2012.
3. Kaushal M, Mishra AK, Raju BS, Ihsan R, Chakraborty A, et al. (2010) Betel quid chewing as an environmental risk factor for breast cancer. Mutat Res 703: 143-148.
4. NCRPINDIA (2006) website, Available: http://ncrpindia.org/Three-Year Reports of Population Based Cancer Registries 2006-2008. Accessed: 31 January 2012.
5. Nair U, Bartsch H, Nair J, (2004) Alert for an epidemic of oral cancer due to use of the betel quid substitutes gutkha and pan masala: a review of agents and causative mechanisms. Mutagenesis 19: 251-262.
6. Lin CF, Wang JD, Chen PH, Chang SJ, Yang YH, et al. (2006) Predictors of betel quid chewing behavior and cessation patterns in Taiwan aborigines. BMC Public Health 6: 271.
7. IARC (2012) Available: http://monographs.iarc.fr/ENG/Monographs/vol85/index.php Accessed: 31 January 2012.
8. Chiang WF, Hung PS, Liu SY, Yuan TC, Chang KW, et al. (2011) Increase of ZASC1 gene copy number in recurrent oral carcinoma. Oral Dis 17: 53-59.
9. Liu SY, Liu YC, Huang WT, Huang GC, Chen TC, et al. (2007) Up-regulation of matrix metalloproteinase-8 by betel quid extract and arecoline and its role in 2D motility. Oral Oncol 43: 1026-1033.
10. Wiseman H, Halliwell B, (1996) Damage to DNA by reactive oxygen and nitrogen species: role in inflammatory disease and progression to cancer. Biochem J 313 (Pt 1): 17-29.
11. Narayan S, Jaiswal AS, Kang D, Srivastava P, Das GM, et al. (2004) Cigarette smoke condensate-induced transformation of normal human breast epithelial cells in vitro. Oncogene 23: 5880-5889.
12. Luo LZ, Werner KM, Gollin SM, Saunders WS, (2004) Cigarette smoke induces anaphase bridges and genomic imbalances in normal cells. Mutat Res 554: 375-385.
13. Baras A, Yu Y, Filtz M, Kim B, Moskaluk CA, (2009) Combined genomic and gene expression microarray profiling identifies ECOP as an upregulated gene in squamous cell carcinomas independent of DNA amplification. Oncogene 28: 2919-2924.
14. Herzog CR, Desai D, Amin S, (2006) Array CGH analysis reveals chromosomal aberrations in mouse lung adenocarcinomas induced by the human lung carcinogen 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone. Biochem Biophys Res Commun 341: 856-863.
15. Singh B, Wreesmann VB, Pfister D, Poluri A, Shaha AR, et al. (2002) Chromosomal aberrations in patients with head and neck squamous cell carcinoma do not vary based on severity of tobacco/alcohol exposure. BMC Genet 3: 22.
16. Gu J, Horikawa Y, Chen M, Dinney CP, Wu X, (2008) Benzo(a)pyrene diol epoxide-induced chromosome 9p21 aberrations are associated with increased risk of bladder cancer. Cancer Epidemiol Biomarkers Prev 17: 2445-2450.
17. Korenaga Y, Matsuyama H, Hirata H, Nagao K, Ohmi C, et al. (2005) Smoking may cause genetic alterations at 5q22.2 approximately q23.1 in clear-cell renal cell carcinoma. Cancer Genet Cytogenet 163: 7-11.
18. Loo LW, Grove DI, Williams EM, Neal CL, Cousens LA, et al. (2004) Array comparative genomic hybridization analysis of genomic alterations in breast cancer subtypes. Cancer Res 64: 8541-8549.
19. Fang M, Toher J, Morgan M, Davison J, Tannenbaum S, et al. (2011) Genomic differences between estrogen receptor (ER)-positive and ER-negative human breast carcinoma identified by single nucleotide polymorphism array comparative genome hybridization analysis. Cancer 117(10): 2024-34.
20. Jonsson G, Naylor TL, Vallon-Christersson J, Staaf J, Huang J, et al. (2005) Distinct genomic profiles in hereditary breast tumors identified by array-based comparative genomic hybridization. Cancer Res 65: 7612-7621.
21. Saama PM, Patel OV, Bettegowda A, Ireland JJ, Smith GW, (2006) Novel algorithm for transcriptome analysis. Physiol Genomics 28: 62-66.
22. Pang H, Hauser M, Minvielle S, (2011) Pathway-based identification of SNPs predictive of survival. Eur J Hum Genet 19: 704-709.
23. Nowak NJ, Gaile D, Conroy JM, McQuaid D, Cowell J, et al. (2005) Genome-wide aberrations in pancreatic adenocarcinoma. Cancer Genet Cytogenet 161: 36-50.
24. Engelman JA, Zejnullahu K, Mitsudomi T, Song Y, Hyland C, et al. (2007) MET amplification leads to gefitinib resistance in lung cancer by activating ERBB3 signaling. Science 316: 1039-1043.
25. Hwang KT, Han W, Cho J, Lee JW, Ko E, et al. (2008) Genomic copy number alterations as predictive markers of systemic recurrence in breast cancer. Int J Cancer 123: 1807-1815.
26. Muenphon K, Limpaiboon T, Jearanaikoon P, Pairojkul C, Sripa B, et al. (2006) Amplification of chromosome 21q22.3 harboring trefoil factor family genes in liver fluke related cholangiocarcinoma is associated with poor prognosis. World J Gastroenterol 12: 4143-4148.
27. Liu J, Wen G, Cao D, (2009) Aldo-keto reductase family 1 member B1 inhibitors: old drugs with new perspectives. Recent Pat Anticancer Drug Discov 4: 246-253.
28. Barski OA, Tipparaju SM, Bhatnagar A, (2008) The aldo-keto reductase superfamily and its role in drug metabolism and detoxification. Drug Metab Rev 40: 553-624.
29. Diez-Dacal B, Gayarre J, Gharbi S, Timms JF, Coderch C, et al. (2011) Identification of aldo-keto reductase AKR1B10 as a selective target for modification and inhibition by prostaglandin A(1): implications for antitumoral activity. Cancer Res 71: 4161-4171.
30. Xu D, Dwyer J, Li H, Duan W, Liu JP, (2008) Ets2 maintains hTERT gene expression and breast cancer cell proliferation by interacting with c-Myc. J Biol Chem 283: 23567-23580.
31. Zabuawala T, Taffany DA, Sharma SM, Merchant A, Adair B, et al. (2010) An ets2-driven transcriptional program in tumor-associated macrophages promotes tumor metastasis. Cancer Res 70: 1323-1333.
32. Ban S, Cologne JB, Neriishi K, (1995) Effect of radiation and cigarette smoking on expression of FUdR-inducible common fragile sites in human peripheral lymphocytes. Mutat Res 334: 197-203.
33. Kao-Shan CS, Fine RL, Whang-Peng J, Lee EC, Chabner BA, (1987) Increased fragile sites and sister chromatid exchanges in bone marrow and peripheral blood of young cigarette smokers. Cancer Res 47: 6278-6282.
34. Chatterjee A, Deb S, (1999) Genotoxic effect of arecoline given either by the peritoneal or oral route in murine bone marrow cells and the influence of N-acetylcysteine. Cancer Lett 139: 23-31.
35. Terry PD, Rohan TE, (2002) Cigarette smoking and the risk of breast cancer in women: a review of the literature. Cancer Epidemiol Biomarkers Prev 11: 953-971.
36. Schembri F, Sridhar S, Perdomo C, Gustafson AM, Zhang X, et al. (2009) MicroRNAs as modulators of smoking-induced gene expression changes in human airway epithelium. Proc Natl Acad Sci U S A 106: 2319-2324.
37. Ambatipudi S, Gerstung M, Gowda R, Pai P, Borges AM, et al. (2011) Genomic profiling of advanced-stage oral cancers reveals chromosome 11q alterations as markers of poor clinical outcome. PLoS One 6: e17250.
38. Purdie KJ, Lambert SR, Teh MT, Chaplin T, Molloy G, et al. (2007) Allelic imbalances and microdeletions affecting the PTPRD gene in cutaneous squamous cell carcinomas detected using single nucleotide polymorphism microarray analysis. Genes Chromosomes Cancer 46: 661-669.
39. Scotto L, Narayan G, Nandula SV, Arias-Pulido H, Subramaniyam S, et al. (2008) Identification of copy number gain and overexpressed genes on chromosome arm 20q by an integrative genomic approach in cervical cancer: potential role in progression. Genes Chromosomes Cancer 47: 755-765.
40. Hodgson JG, Chin K, Collins C, Gray JW, (2003) Genome amplification of chromosome 20 in breast cancer. Breast Cancer Res Treat 78: 337-345.
41. Nakao K, Mehta KR, Fridlyand J, Moore DH, Jain AN, et al. (2004) High-resolution analysis of DNA copy number alterations in colorectal cancer by array-based comparative genomic hybridization. Carcinogenesis 25: 1345-1357.
42. Honma K, Iwao-Koizumi K, Takeshita F, Yamamoto Y, Yoshida T, et al. (2008) RPN2 gene confers docetaxel resistance in breast cancer. Nat Med 14: 939-948.
43. Kane AJ, Sughrue ME, Rutkowski MJ, Phillips JJ, Parsa AT, (2010) EMR-3: a potential mediator of invasive phenotypic variation in glioblastoma and novel therapeutic target. Neuroreport 21: 1018-1022.
44. Fernandez-Zapico ME, Gonzalez-Paz NC, Weiss E, Savoy DN, Molina JR, et al. (2005) Ectopic expression of VAV1 reveals an unexpected role in pancreatic cancer tumorigenesis. Cancer Cell 7: 39-49.
45. Lazer G, Idelchuk Y, Schapira V, Pikarsky E, Katzav S, (2009) The haematopoietic specific signal transducer Vav1 is aberrantly expressed in lung cancer and plays a role in tumourigenesis. J Pathol 219: 25-34.
46. Uchihara T, Okubo C, Tanaka R, Minami Y, Inadome Y, et al. (2007) Neuronatin expression and its clinicopathological significance in pulmonary non-small cell carcinoma. J Thorac Oncol 2: 796-801.
47. Vasudev NS, Trigonis I, Cairns DA, Hall GD, Jackson DP, et al. (2011) The prognostic and predictive value of CA-125 regression during neoadjuvant chemotherapy for advanced ovarian or primary peritoneal carcinoma. Arch Gynecol Obstet 284: 221-227.
48. Lakshmanan I, Ponnusamy MP, Das S, Chakraborty S, Haridas D, et al. (2012) MUC16 induced rapid G2/M transition via interactions with JAK2 for increased proliferation and anti-apoptosis in breast cancer cells. Oncogene 31(7): 805-17.
49. Reinartz S, Failer S, Schuell T, Wagner U, (2012) CA125 (MUC16) gene silencing suppresses growth properties of ovarian and breast cancer cells. Eur J Cancer 48(10): 1558-69.
50. Luo M, Guan JL, (2010) Focal adhesion kinase: a prominent determinant in breast cancer initiation, progression and metastasis. Cancer Lett 289: 127-139.
51. Zhou Y, Eppenberger-Castori S, Eppenberger U, Benz CC, (2005) The NFkappaB pathway and endocrine-resistant breast cancer. Endocr Relat Cancer 12 (Suppl 1):: S37-46.
52. Ferroni P, Roselli M, Martini F, D'Alessandro R, Mariotti S, et al. (2004) Prognostic value of soluble P-selectin levels in colorectal cancer. Int J Cancer 111: 404-408.
53. Ghayad SE, Vendrell JA, Bieche I, Spyratos F, Dumontet C, et al. (2009) Identification of TACC1, NOV, and PTTG1 as new candidate genes associated with endocrine therapy resistance in breast cancer. J Mol Endocrinol 42: 87-103.
54. Tzeng HE, Chen JC, Tsai CH, Kuo CC, Hsu HC, et al. (2011) CCN3 increases cell motility and MMP-13 expression in human chondrosarcoma through integrin-dependent pathway. J Cell Physiol 226: 3181-3189.
55. Ouellet V, Tiedemann K, Mourskaia A, Fong JE, Tran-Thanh D, et al. (2011) CCN3 impairs osteoblast and stimulates osteoclast differentiation to favor breast cancer metastasis to bone. Am J Pathol 178: 2377-2388.
56. Neal CL, Yu D, (2010) 14-3-3zeta as a prognostic marker and therapeutic target for cancer. Expert Opin Ther Targets 14: 1343-1354.
57. Lin M, Morrison CD, Jones S, Mohamed N, Bacher J, et al. (2009) Copy number gain and oncogenic activity of YWHAZ/14-3-3zeta in head and neck squamous cell carcinoma. Int J Cancer 125: 603-611.
58. Bergamaschi A, Katzenellenbogen BS, (2012) Tamoxifen downregulation of miR-451 increases 14-3-3zeta and promotes breast cancer cell survival and endocrine resistance. Oncogene 31: 39-47.
59. Liao DJ, Dickson RB, (2000) c-Myc in breast cancer. Endocr Relat Cancer 7: 143-164.
60. Sakamuro D, Prendergast GC, (1999) New Myc-interacting proteins: a second Myc network emerges. Oncogene 18: 2942-2954.
61. Yeh PY, Lu YS, Ou DL, Cheng AL, (2011) IkappaB kinases increase Myc protein stability and enhance progression of breast cancer cells. Mol Cancer 10: 53.
62. Jonsson G, Naylor TL, Vallon-Christersson J, Staaf J, Huang J, et al. (2005) Distinct genomic profiles in hereditary breast tumors identified by array-based comparative genomic hybridization. Cancer Res 65: 7612-7621.
63. Das AJ, Deka SC, (2012) Fermented foods and beverages of the North-East India. International Food Research Journal 19(2): 377-392.
64. Dal Maso L, Zucchetto A, Talamini R, Serraino D, Stocco CF, et al. (2008) Effect of obesity and other lifestyle factors on mortality in women with breast cancer. Int J Cancer 123: 2188-2194.
65. Beaber EF, Holt VL, Malone KE, Porter PL, Daling JR, et al. (2008) Reproductive factors, age at maximum height, and risk of three histologic types of breast cancer. Cancer Epidemiol Biomarkers Prev 17: 3427-3434.
66. Sangrajrang S, Sato Y, Sakamoto H, Ohnami S, Laird NM, et al. (2009) Genetic polymorphisms of estrogen metabolizing enzyme and breast cancer risk in Thai women. Int J Cancer 125: 837-843.
67. George RE, Attiyeh EF, Li S, Moreau LA, Neuberg D, et al. (2007) Genome-wide analysis of neuroblastomas using high-density single nucleotide polymorphism arrays. PLoS One 2: e255.
68. Turner N, Lambros MB, Horlings HM, Pearson A, Sharpe R, et al. (2010) Integrative molecular profiling of triple negative breast cancers identifies amplicon drivers and potential therapeutic targets. Oncogene 29: 2013-2023.
69. Benjamini Y, Drai D, Elmer G, Kafkafi N, Golani I, (2001) Controlling the false discovery rate in behavior genetics research. Behav Brain Res 125: 279-284.
70. Huang da W, Sherman BT, Lempicki RA, (2009) Systematic and integrative analysis of large gene lists using DAVID bioinformatics resources. Nat Protoc 4: 44-57.